Moreover, treatment of AGS gastric cancer cells with nutlin‐3a, a known p53 activator, led to a pronounced reduction in the protein levels of OTUD5 and GPX4 (Figure 4B), as well as an inhibition of cell proliferation (Figure S3A). This evidence concerns the gene TP53 and gastric cancer.